Back to Search Start Over

Radiolabeled HER2-directed exosomes exhibit improved cell targeting and specificity.

Authors :
Ghavami M
Vraka C
Hubert V
Schachner H
Bamminger K
Hacker M
Kain R
Moghadam MF
Source :
Nanomedicine (London, England) [Nanomedicine (Lond)] 2021 Mar; Vol. 16 (7), pp. 553-567. Date of Electronic Publication: 2021 Mar 17.
Publication Year :
2021

Abstract

Aim: Here, we established a reliable strategy for generation and characterization of targeted radiolabeled exosomes for the detection of HER2-positive cells quantitatively. Materials & methods: Targeted exosomes (T-exos) were radiolabeled by two different radiotracers, [ <superscript>99m</superscript> Tc]Tc-HMPAO or [ <superscript>111</superscript> In]In-oxine. The labeling efficiency and stability were assessed using exosome exclusive spin columns. HER2-positive and -negative cells were treated with [ <superscript>111</superscript> In]In-oxine-exosomes after 3 and 24 h. Results: [ <superscript>111</superscript> In]In-oxine labeling did not change the binding ability and general features of the exosomes. With [ <superscript>111</superscript> In]In-oxine, 70% labeling efficiency and 78% radiochemical stability over 24 h were achieved. [ <superscript>111</superscript> In]In-oxine-T-exos showed greater uptake by HER2-positive cells compared with untargeted exosomes. Conclusion: [ <superscript>111</superscript> In]In-oxine-T-exos could potentially be used as an effective imaging tool for HER2 expression.

Details

Language :
English
ISSN :
1748-6963
Volume :
16
Issue :
7
Database :
MEDLINE
Journal :
Nanomedicine (London, England)
Publication Type :
Academic Journal
Accession number :
33728944
Full Text :
https://doi.org/10.2217/nnm-2020-0408